VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
131 hedge funds and large institutions have $191M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $260M → $191M (-$68.6M)
Holders
131
Holding in Top 10
–
Calls
$1M
Puts
$383K
Top Buyers
| 1 | +$6.38M | |
| 2 | +$1.23M | |
| 3 | +$894K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$632K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$536K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.38M | |
| 3 | -$790K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$408K |
| 5 |
Goldman Sachs
New York
|
-$249K |